Lakefront Biotherapeutics launches €50 million share buyback program
Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) announced the launch of a share repurchase program worth up to €50 million ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
